Invest in Pfizer and Altria Group for Steady Dividend Income and Growth Potential
Friday, 12 April 2024, 10:07
Key Points:
Income-seeking investors face a crucial decision when choosing dividend stocks to buy. Pfizer and Altria Group currently stand out with yields above 6% and a consistent track record of raising dividends annually.
Pfizer's Outlook:
- Dividend History: Pfizer has increased its dividend for 15 consecutive years.
- Sales Impact: Despite COVID-19 product sales decline, total sales grew by 7% last year.
- Future Prospects: Expected earnings growth to support dividend payouts and potential for new drug development.
Altria Group's Standing:
- Dividend Growth: Altria has raised its dividend 58 times in the last 54 years.
- Market Challenges: Shift away from combustible cigarettes affecting sales, while focusing on e-vapor products for future growth.
- Regulatory Environment: FDA restrictions pose challenges but also opportunities for market expansion.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.